Reporting of adverse drug reactions in randomised controlled trials – a systematic survey
Open Access
- 12 September 2001
- journal article
- research article
- Published by Springer Nature in BMC Clinical Pharmacology
- Vol. 1 (1), 3
- https://doi.org/10.1186/1472-6904-1-3
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trialsThe Lancet, 2001
- Completeness of Safety Reporting in Randomized TrialsJAMA, 2001
- Reporting of Adverse Effects in Clinical Trials Should Be Improved: Lessons from Acute Postoperative PainJournal of Pain and Symptom Management, 1999
- Meta-style and expert reviewThe Lancet, 1999
- beta Blockade after myocardial infarction: systematic review and meta regression analysisBMJ, 1999
- Influence of Non-steady State During Isoglycemic Hyperinsulinemic Clamp in Hypertension: A LIFE SubstudyBlood Pressure, 1999
- Adverse Drug Reactions in Current Antihypertensive Therapy: a General Practice Survey of 2586 Patients in NorwayBlood Pressure, 1999
- Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)The Lancet, 1997
- Better reporting of randomised controlled trials: the CONSORT statementBMJ, 1996
- A Proposal for Structured Reporting of Randomized Controlled TrialsJAMA, 1994